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FGF2 Concentration Regulates the Generation
of Neurons and Glia from Multipotent
Cortical Stem Cells
Xueming Qian, Andrew A. Davis,* Susan K. Goderie, and recent evidence has emerged for multipotent corti-
cal cells with stem-like properties in vivo (Reid et al.,and Sally Temple
Department of Pharmacology and Neuroscience 1995). Hence, cortical neurons and glia may arise from
multipotent founder cells via restricted progenitor cells;A-136
Albany Medical College a similar mechanism is thought to underlie histogenesis
in other CNS regions and also in the peripheral nervousAlbany, NY 12208
system (Anderson, 1989; Kilpatrick et al., 1995; Temple
and Qian, 1996).
Production of diverse cell types by multipotent pro-Summary
genitor cells is likely to be influenced by intrinsic and
environmental factors (see reviews by Reh and Cagan,The embryonic cerebral cortex contains a population
1994; Calof, 1995; Jan and Jan, 1995). Although neuralof stem-like founder cells capable of generating large,
stem cells are competent to generate neurons, astro-mixed clones of neurons and glia in vitro. We report
cytes, and oligodendrocytes, it is not clear to what ex-that the default state of early cortical stem cells is
tent these fates are specified intrinsically or throughneuronal, and that stem cells are heterogeneous in the
environmental factors. It is possible that neural stemnumber of neuronsthat they generate. In low fibroblast
cells are intrinsically programmed to randomly generategrowth factor (FGF2) concentrations, most maintain
progeny of all these fates, and that the environmentthis specification, generating solely neuronal progeny.
selects among the different progeny to regulate the de-Oligodendroglial production within these clones is
velopment of stem cells. Another possibility is that neu-stimulated by a higher, threshold level of FGF2, and
ral stem cells may be programmed to generate just oneastrocyte production requires additional environmen-
of these fates as a default state, and environmentaltal factors. Because most cortical neurons are born
factors may direct them into other lineage pathways.before glia in vivo, these data support a model in which
No environmental factors have yet been identified thatthe scheduled production of cortical cells involves an
play a role in directing cell fate choices in multipotentintrinsic neuronal program in the early stem cells and
cells from the early embryonic ventricular zone, althoughexposure to environmental, glia-inducing signals.
progenitor cells derived from the later-arising subven-
tricular zone have recently been shown to be pushedIntroduction
into theastrocyte lineage by bone morphogenic proteins
(BMPs) (Gross et al., 1996).The complex functions of the cerebral cortex rely on
To investigate the characteristics of progenitor cellsthe interplay of a large number of different cell types,
in the cortical ventricular zone and to address how fac-including many classes of neurons and two major
tors in their environment might influence their develop-classes of macroglial cells–astrocytes and oligodendro-
ment into different lineages, we have established acytes. These cells arise on a precise time schedule from
clonal culture system that allows us to follow the fatethe cortical ventricular zone, a germinal layer of neuro-
of identified cells under controlled conditions. Our previ-epithelial cells present through embryogenesis (Jacob-
ous studies showed that the development of neuronsson, 1991; Bayer and Altman, 1991). Distinct types of
and glia from isolated cortical ventricular zone cells isneurons produced at specific times are assembled into
promoted by complex culture conditions that includedifferent cortical layers according to their birth dates
currently uncharacterized membrane-associated fac-(Angevine and Sidman, 1960; McConnell, 1995). Ventric-
tors (Temple and Davis, 1994). One of these factorsular zone cells also generate a second germinal region,
could be fibroblast growth factor 2 (FGF2), also knownthe subventricular zone, from which the majority of glia
as basic FGF, a growth factor widely expressed in thearise. In the cerebral cortex, as in most central nervous
system (CNS) regions, the majority of neurons are born embryonic CNS (reviewed in Baird, 1994) that has been
before glia (Bayer and Altman, 1991). The mechanisms shown to have a mitogenic action on a variety of fore-
underlying the scheduled production of diverse types brain CNS progenitor cells (reviewed in Temple and
of cortical cells are not yet clear. Qian, 1995; Kilpatrick et al., 1995; Gritti et al., 1996).
Clonal analyses investigating how cortical neurons FGF2 exists in several isoforms that vary in size and
and glia are generated on a cellular level have revealed distribution. The 18KD form is associated with the cyto-
that the cortical ventricular zone contains multipotent sol and the cell surface; the 22, 23, and 24KD isoforms
progenitor cells that generate mixed neuron–glia clones are localized in the nucleus (Renko et al., 1990; Florkie-
and progenitor cells that appear restricted to forming wicz et al., 1991; reviewed by Mason, 1994). The 18KD
either neurons or glia (reviewed in Kilpatrick et al., 1995; form is also observed outside cells, including those in
Temple and Qian, 1996). In vitro studies have demon- the cortical ventricular zone (Weise et al., 1993). Be-
strated that some multipotent cortical cells can self- cause FGF2 lacks a classical signal sequence, there has
renew, a hallmark of stem cells (Davis and Temple, 1994), been some controversy regarding whether it can be
secreted, or whether cells only release FGF2 when their
plasma membrane iscompromised (Mason, 1994). How-*Present address: Department of Biological Structure, University of
Washington, Box 357420, Seattle, WA 98195. ever, recent studies indicate that the 18KD form of FGF2
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can be secreted through an alternative, energy-depen- isoforms of each of the four cloned FGF receptors. As
shown in Figure 1a, we found that the IIIc isoforms ofdent non-ER/golgi pathway (Mignatti et al., 1992; Flor-
kiewicz et al., 1995). FGF1 and FGF9, which also lack a FGFR1, 2, and 3 are expressed by embryonic cortical
cells at all three ages, but FGFR1 IIIa and IIIb isoformsclassical signal sequence, also seem to use alternative
secretory routes (Mason, 1994). were not detected (Figure 1b). FGFR3 IIIb was not de-
tected at the three ages tested either (data not shown).The expression of FGF2 in thedeveloping murine brain
is complex: while it is detected as early as embryonic These data demonstrate that mRNAs for multiple FGF
receptor isoforms with different affinities are present inday 9.5 (E9.5) in cerebral cortex (Nurcombe et al., 1993),
both mRNA and protein levels of the 18KD isoform in- the murine cerebral cortex as early as E10 and through
E14. This opens thepossibility that FGF2 could influencecrease dramatically from E14 to E18 and then drop to
lower levels postnatally (Powell et al., 1991; Giordano development of cortical ventricular zone cells, as early
as E10, before differentiated neurons and glial cellset al., 1992; Weise et al., 1993). Since murine cortical
neurogenesis occurs largely from E10–E18 and gliogen- appear.
esis from E15 through early postnatal ages (Jacobson,
1991; Bayer and Altman, 1991), changes in FGF2 levels
FGF2 Supports Development of Both Mixedobserved in vivo are concurrent with specific phases
and Uniform Clones from Early Embryonicof cortical histogenesis, and the transient rise in FGF2
Cerebral Ventricular Zone Cellsexpression is coincident with the peak of neurogenesis
Previous work has described FGF2 as a mitogen forand early stages of gliogenesis. These observations led
early embryonic cortical progenitor cells in conjunctionus to examine in detail the influence of FGF2 on the
with either cell–cell contact (Ghosh and Greenberg,development of early embryonic cortical ventricular
1995) or serum factors (Kilpatrick and Bartlett, 1993),zone cells. We now report that in addition to its actions
stimulating us to test whether FGF2 could act as a mito-as a mitogen for cortical progenitor cells, our results
gen for cortical progenitor cells without these additionalshow that FGF2 has a dramatic, concentration-depen-
factors. As a first step, we quantified the mitogenic influ-dent influence on the types of progeny that they gener-
ence of FGF2 on isolated cells growing in serum-freeate. In basal medium and in low levels of FGF2, E10
medium using BrdU uptake as an indicator of cell prolif-stem cells exhibit a neuronal fate. Increasing the FGF2
eration. Single cortical cells were plated at low densitylevel in the environment of multipotent cortical founder
(approximately 20–40 cells per mm2) in Terasaki wellscells induces them to generate glial progeny in addition
in the presence of 0–10 ng/ml recombinant human FGF2to neurons.
in basal, serum-free culture medium. BrdU was added
24–42 hr after plating, and incorporation was assessed
by counting the percentage of cells with nuclear anti-Results
body staining for BrdU. Data points, shown in Figure 2,
show an exponential relationship between BrdU incor-Multiple FGF Receptors Are Expressed in the Early
Embryonic Cerebral Cortex poration and FGF2 dosage. The Ed50 is 0.11 ng/ml, equiv-
alent to 6.7 pM. This is compatible with results obtainedTo begin to investigate the possible roles of FGF2 in the
cerebral cortical development, we examined the expres- for FGF2 stimulation of mouse telencephalic and mesen-
cephalic cell proliferation (Ed50 5 0.14 ng/ml) (Murphysion of FGF receptors in early cortical ventricular zone
cells using reverse-transcription polymerase chain reac- et al., 1990).
Having shown that FGF2 promotes BrdU incorpora-tion (RT-PCR). There are four cloned FGF receptors, and
each has a number of isoforms generated by alternative tion in isolated cortical ventricular zone cells in a short-
term assay, we investigated whether it could supportsplicing. FGF2 binds with different affinities to different
isoforms of FGFR1–3; for example, it has highest affinity their long-term development. E10 cells were plated into
Terasaki wells, averaging 2–3 cells per well (at this den-for FGFR1 IIIc, but 10-fold lower affinity for FGFR3 IIIc
(reviewed in Johnson and Williams, 1993). Previous sity, the development of each cell can be followed), and
cultured in basal, serum-free culture medium with orstudies have shown that some FGF receptors are ex-
pressed in the embryonic murine cortex, but not all iso- without 10 ng/ml (670 pM) FGF2 for up to 2 weeks. In
basal medium alone, the majority of plated cells differen-forms have been examined (Yamaguchi et al., 1992; Orr-
Urtreger et al., 1993; Peters et al., 1993). In addition, few tiated into single neurons. Only approximately 1% di-
vided to generate clones of four or more progeny, andstudies have examined FGFR expression patterns in the
cerebral cortex as early as E10. Hence, we investigated these were found to consist solely of neurons; of more
than 300 E10 clones growing in basal medium examined,the expression of mRNA for each FGFR isoform known
to bind FGF2 in the cerebral cortex at three early embry- no glia-containing clones were detected. In the pres-
ence of 10 ng/ml FGF2, a significantly greater percent-onic ages (E10, E12, and E14).
At E10 and E12, the murine cerebral cortex contains age, 8%–10%, of the original plated cells divided to
generate clones of $4 cells.almost exclusively neuroepithelial, ventricular zone
cells. By E14, some differentiated cells are present, but We examined whether the increase in the percentage
of dividing cells was because FGF2 was acting as athe majority of the tissue still consists of ventricular zone
cells (Bayer and Altman, 1991). Cortices were dissected survival factor for a subset of cells that normally died
in basal medium or whether FGF2 stimulated divisionfrom timed pregnant animals at the three ages, and RT-
PCR was performed. Seven pairs of PCR primers were of cells that survived but did not divide in basal medium.
Survival of cells in basal medium was 72% 6 3.1% fordesigned, based on those used previously (Brickman
et al., 1995, and references therein) to detect specific the first 24 hr of culture, and for cells growing in 10 ng/
FGF2 and Stem Cells in Cerebral Cortex
83
Figure 1. Expression of FGF Receptor Iso-
forms in Cortical Ventricular Zone Cells
Total RNA was isolated from freshly dis-
sected E10, E12, and E14 mouse cerebral
cortex, and cDNAs were synthesized with
random primers using AMV reverse tran-
scriptase, followed by PCR amplification us-
ing FGFR isoform specific primers. Negative
controls (2) were cDNAs prepared using the
same procedures except without reverse
transcriptase.
(a) Expression of IIIc isoforms of FGFR1, 2,
and 3 in E10, E12, and E14 cerebral cortex.
(b) Expression of the IIIc but not the IIIa, or
IIIb isoforms of FGFR1. mRNAs for FGFR3
IIIb and FGFR4 were not detected (data not
shown). The PCR products for FGFR1 IIIc,
FGFR2 IIIc, and FGFR3 IIIc isoforms are 348
bp, 340 bp, and 345 bp, respectively. M indi-
cates a 100 bp ladder DNA marker.
ml FGF2, it was 72% 6 2.1% (Figure 3b). Hence, there Clones developing in 10 ng/ml FGF2 were character-
ized by staining with cell-type-specific markers: anti-appears to be no significant influence of FGF2 at least
on the short-term survival of E10 cortical ventricular beta-tubulin isotype III for neurons, anti-glial fibrillary
acidic protein (GFAP) for astrocytes, and O4 antibodyzone cells under these culture conditions, and we con-
clude that it is likely that in most cases FGF2 promotes for oligodendrocyte lineage cells. We assessed the
specificity of the anti-beta-tubulin III antibody in ourdivision of cells that normally survive but do not divide
in basal medium. culture system and found that it labels immature and
Figure 2. Dose-Dependent Proliferative Re-
sponse of Cortical Ventricular Zone Cells to
FGF2
Cortical ventricular zone cells were cultured
in different concentrations of recombinant
human FGF2. Cells that incorporated BrdU,
indicating cell proliferation, over day 1–2 of
culture were identified using immunostaining.
The percentage of cells that incorporated
BrdU was quantified as a function of FGF2
concentration. This generated an exponential
dose-dependent response curve, with Ed50 5
0.109 ng/ml FGF2.
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influence of different FGF2 concentrations on cortical
ventricular zone cell development. E10 cells were plated
in basal culture medium containing various levels of
FGF2: 0, 0.1, 1, or 10 ng/ml at a density averaging 2–3
cells per Terasaki well. The percentage of plated cells
that divided to generate $4 cells was consistently 8%–
10% for cultures growing in 0.1–10 ng/ml FGF2, and
around 1% in basal medium. Although BrdU incorpora-
tion indicates an increase in cell proliferation over this
FGF2 dose range, most responding cells were found to
generate less than four progeny, while the proportion
generating four or more cells remained relatively con-
stant at 8%–10%. In addition, cell survival over the first
24 hr of culture was similar (Figure 3b). Cells were cul-
tured for 10–12 days, and fed with fresh FGF2 every
2–3 days to maintain appropriate growth factor levels.
Cultures were then fixed and stained with cell-type-spe-
cific antibodies, as described above. Clones were cate-
gorized into three classes: neuron-only, mixed (neuron
plus glia), and glia-only. As shown in Figure 3a (repre-
senting data from three experiments), the percentage
of clones in these categories changed markedly with
increasing FGF2 concentration. In 0.1 ng/ml FGF2, ap-
proximately 92% of clones were neuron-only, while only
approximately 8% of the clones contained both neurons
and glia, and <1% were pure glia. In contrast, in 10 ng/
ml FGF2, only 15% of clones were neuron-only, 69%
were mixed, and 16% were pure glia. These data demon-
strate that E10 cortical ventricular zone cells respond to
Figure 3. Varying FGF2 Concentration Alters the Composition of
increasing FGF2 concentrations by dramatically alteringE10 Cortical Ventricular Zone Clones
clone composition. The types of clones generated in(a) E10 cortical ventricular zone cells plated at 2–3 cells per Terasaki
different levels of FGF2 are illustrated in Figure 4.well were grown in basal culture medium or medium supplemented
with 0.1, 1.0, or 10.0 ng/ml FGF2. Cultures were maintained for 12
days, then fixed and stained with cell-type specific antibodies: beta-
tubulin III for neurons, GFAP for astrocytes, and O4 for oligodendro- The Fate of a Single Multipotent Cell Is Altered
cyte lineage cells. Clones were classified into three categories: neu- with Increasing FGF2 Concentration
ron only, mixed neuron–glial, and glia only. Data represent mean 6 Changes in the composition of clones growing in differ-
SEM of three independent experiments with more than 100 clones
ent FGF2 levels could be brought about by two differentfor each condition. There was a dramatic decline in the percentage
mechanisms. FGF2 concentration could alter the fateof pure neuron clones and an increase in the percentage of clones
of individual multipotent founder cells. Alternatively, itthat contained glial cells with increasing FGF2 concentration.
(b) There was no significant effect of adding FGF2 to basal medium, could selectively promote development of different pro-
at the concentrations tested, on cell survival over the first 24 hr of genitor cell types that might exist within the starting
culture. The number of cells plated in each condition was counted population–for example, 0.1 ng/ml FGF2 could preferen-
2 hr after plating and again at 24 hr after plating to generate the
tially stimulate development of progenitor cells fatedpercentage survival. For each condition, about 300–350 cells were
to generate neuron-only clones, and 1–10 ng/ml couldcounted per experiment.
preferentially stimulate progenitor cells fated to give
mixed, neuron–glial clones. We tested these two alterna-
tives using the following experimental paradigm.mature neurons, while multipotent progenitor cells, oli-
godendrocyte precursors, and other glial lineage cells Single E10 cortical ventricular zone cells were plated,
averaging 2–3 cells per Terasaki well, in basal mediumremain unlabeled. In the presence of 10 ng/ml FGF2
(Figure 3a), both mixed (69% of clones) and uniform with 0.1 ng/ml of FGF2. After 48 hr of culture, cells that
had divided were identified by microscopic observation,(15% neuron-only and 16% glia-only) clones developed.
These results show that FGF2 supports development then the culture medium was changed to one of the
following three conditions: 0.1, 1, or 10 ng/ml FGF2.of multipotent cells and cells that appear restricted in
potency, and that it does so without serum or initial Clones were cultured for 10 more days, fed with fresh
FGF2 every 48–72 hr to maintain appropriate growthcell–cell contact.
factor levels, then fixed and stained with cell-type-spe-
cific antibodies. Controls for this experiment includedVarying FGF2 Concentration Alters
the Neuron–Glial Composition growing cells in basal medium, 1 ng/ml FGF2 or 10 ng/
ml FGF2 throughout the culture period.of Cortical Clones
Since the level of FGF2 expression varies during CNS The percentage of cells that divided to generate four
or more cells was 8%–10% for all FGF2 treatments,(including cortical) histogenesis (Powell et al., 1991; Gi-
ordano et al., 1992; Weise et al., 1993), we examined the and cells that did not divide in the initial 2 days of the
FGF2 and Stem Cells in Cerebral Cortex
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Figure 4. Clonal Types Generated in Different Concentrations of FGF2
E10 cortical ventricular zone cells were grown for 12 days in different FGF2 concentrations and stained with cell-type-specific antibodies as
described in the Figure 3 legend. Sections of clones from different categories are shown.
(A–B) Neuron-only clone grown in 0.1 ng/ml FGF2.
(C–D) and (E–F) Mixed clones containing both neurons and glia grown in 1 ng/ml FGF2.
(G–H) Glia-only clone grown in 10 ng/ml. (A), (C), (E), and (G) are phase-contrast images of fields shown stained for beta-tubulin III ([B], [D],
[E]) or O4 [H]). None of these clones contained astrocytes, judged by lack of GFAP labeling (not shown).
(J–L) Illustrates a clone cultured in 10 ng/ml FGF2 with serum-free, astrocyte–meningeal cell-conditioned medium. (J) Phase image.
(K) Beta-tubulin III.
(L) GFAP. Note that a large number of the glial cells present in the (J–L) series are GFAP-positive astrocytes. Scale bars, 50 mm.
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Figure 5. FGF2 Concentration-Dependent Cell
Fate Switch in Single Multipotent Cortical
Ventricular Zone Cells
E10 cortical ventricular zone cells weregrown
for 48 hr in 0.1 ng/ml FGF2, then switched to
either 0.1, 1, or 10 ng/ml FGF2 (designated
0.1 1 0.1, 0.1 1 1, and 0.1 1 10, respectively)
for another 10 days before fixation and stain-
ing with cell-type-specificantibodies. Control
cells were cultured in basal medium (0 ng/ml
FGF2), 0.1, 1, or 10 ng/ml FGF2 throughout
the experiment. Cells that responded to the
low level of FGF2 were identified and followed
after being switched to new medium at the
48 hr time point. More than 50 clones were
examined in each condition. This experiment
shows that the same group of founder cells
that responds to low levels of FGF2 goes on
to generate glia if the FGF2 concentration is
raised at 48 hr. These data indicate that in-
terclonal selection cannot explain the switch
in cell fate.
experiment in 0.1 ng/ml FGF2 also did not divide when High Levels of FGF2 Stimulate Production of Glial
Progeny from Multipotent Stem Cellsthe FGF2 concentration was raised after 48 hr. This
Although we demonstrated that single multipotent pro-shows that only cells initially responding to 0.1 ng/ml
genitor cells can alter their fate in response to changesFGF2 generated clones. The results of one experiment
in FGF2 level (indicating changes in clone compositionare shown in Figure 5. When cells were maintained in
were not primarily a result of selection among the plated0.1 ng/ml FGF2 throughout the culture period, 81% gen-
population), the possibility remained that FGF2 levelserated neuron-only clones, as expected from previous
could act selectively within a developing clone. For ex-experiments (see Figure 3). However, when cells were
ample, multipotent progenitor cells may generate differ-changed from 0.1 ng/ml into 1 ng/ml FGF2 or into 10
ent types of restricted progenitor cells randomly, andng/ml FGF2, clonal composition was altered: neuron-
subpopulations could be selected to survive in differentglia clones increased from 17.2% to 49.9% and 47.6%,
FGF2 environments. Alternatively, FGF2 may act to alterrespectively, and concomitantly, neuron-only clones de-
the types of progeny produced by multipotent cells. Ifcreased from 82.8% to 50% and 52%, respectively.
intraclonal selection were operating, neuron-only clonesThere are some inconsistencies in the data, such as the
arising in 0.1 ng/ml FGF2 should also include glial pro-lack of glia-only clones in 10 ng/ml, probably due to
genitors that either die or do not develop. Although itexperimental variation (the histogram illustrates a single
is difficult to account for the fate of every cell arising inexperiment). Nevertheless, the overall trend is clear–an
large clones, approximately two thirds of E10 progenitorincrease in clones generating glial cells with increasing
cells growing in 0.1 ng/ml FGF2 generate clones of <16FGF2 concentration. The percentage of cells that di-
cells, and these can be examined in detail. By followingvided was 8%–10% at all FGF2 treatments, and cells
their development by daily microscopic observation, we
that did not divide in the initial 2 days of the experiment
found that >90% of these clones arose with no detect-
in 0.1 ng/ml FGF2 also did not divide when the FGF2
able cell death. It is unlikely that some cells died and
concentration was raised after 48 hr. This shows that
their debris was cleared away within 24 hr because by
only cells initially responding to 0.1 FGF2 generated observing cell behavior extensively in this culture sys-
clones in this experiment. If the FGF2 effect resulted tem, in some cases using time-lapse recording, we find
from interclonal selection, then we would not expect to that debris from dead cells is invariably visible in small
alter the fate of cells that initially divided in response to clones for more than 24 hr, in fact usually for more than
the low level of FGF2. In fact, approximately 40% of E10 3 days. (This is probably because cells in these small,
cells originally fated to produce neuron-only clones (by isolated clones growing in microwells are not exposed
growth in 0.1 ng/ml FGF2) generated neuron–glia clones to microglia or macrophages that can rapidly clear de-
after exposure to higher FGF2 concentrations. Thus, bris in vivo or in mass cultures). Thus, daily observation
higher levels of FGF2 stimulated glial development should be sufficient to detect dead cells, at least in small
within the same group of founder cells that responded clones, and we conclude that in these cases cell death
to low doses of FGF2, indicating that the effect of FGF2 is a relatively rare event. In contrast, a low level of cell
cannot be explained by interclonal selection. This dem- death was consistently observed during later stages
onstrates directly that the responding E10 cells are of the development of larger clones, leaving open the
multipotent, and that raising the FGF2 concentration possibility of selection by differential cell survival oc-
from 0.1 to 1 or 10 ng/ml alters the types of progeny curring within these clones.
An alternative selection mechanism might operate,that they generate.
FGF2 and Stem Cells in Cerebral Cortex
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Table 1. Analysis of clone size and composition in different
levels of FGF2
Mean
FGF2 conc. number Percentage
(ng/ml) Clone type of cells/clone of clones
0.1 N , 16 9.2 65.6
N . 16 29.3 25.2
NG , 32 16.9 7.9
NG 32–100 75.0 0.7
NG . 100 0.0 0.0
G 60.0 0.6
1 N , 16 9.7 28.1
N . 16 35.7 4.8
NG , 32 18.8 28.7
NG 32–100 54.9 25.3
NG . 100 145 8.9
G 10 4.2
10 N , 16 9.1 16.9
N . 16 22.3 2.9
NG , 32 18.6 25.0
NG 32–100 64.9 24.3
NG . 100 205 19.9
G 22.5 11.0
Clones generated in different FGF2 doses were analyzed with re-
spect to clone size and neuron–glial content. Note the heterogeneity
in clone size and composition. N 5 neuron-only clones; NG 5 mixed
neuron–glial clones; and G 5 glia-only clones.
not via differential cell death, but by producing glial
progenitor cells that do not develop at 0.1 ng/ml FGF2.
However, only approximately 10% of these small (<16
cells) neuron-only clones contained cells that were beta-
tubulin III negative, showing that in the remaining ap-
proximately 90% of clones, glial progenitor cells did not
remain undeveloped. We conclude that the difference
in clone composition in 0.1 ng/ml versus 1–10 ng/ml
FGF2 cannot be explained by intraclonal selection. In-
stead, our data demonstrate that high levels of FGF2
act to stimulate multipotent founder cells to generate
glial lineage progeny.
E10 Stem Cells Generate Heterogeneous
Clones–Quantitation of the Influence
of Increase in FGF2 Concentration
on Neuron and Glial Production
E10 cortical ventricular zone cells growing in any of Figure 6. Changes in FGF2 Concentration from 0.1–10 ng/ml Have
these three levels of FGF2 were found to generate het- a Dramatic Influence on Glial Content but Not Neuron Content of
Cloneserogeneous clones that varied markedly in size and/or
composition, as illustrated in Table 1. There is no clear To address the influence of FGF2 doses from 0.1–10 ng/ml on clone
composition, clones generated as described in Figure 3 were ana-relationship between the number of neurons and the
lyzed based on neuron and glia content.number of glia in a given clone. Hence, to get a clear
(a) The frequency of clones categorized according to the numberpicture of how clones were being influenced by changes
of neurons they contain, shown for 0.1, 1, and 10 ng/ml FGF2.
in FGF2 concentration, we organized them according (b) The percentage of clones in those categories that also contain
to different aspects of their composition. glial cells.
To quantitate the effect of FGF2 concentration on (c) Summarizes the mean number of neurons generated at the three
FGF doses and the mean percentage of clones that contained glia.neuron production, we determined the frequency of
Note that in these figures, the number of glial cells per clone is notclones of $4 cells with different numbers of neurons,
taken into account, only the presence or absence of any glia at all.regardless of the number of glia that they contained.
These data show that over this range of FGF2 doses, a similar
Figure 6a illustrates the distributions of these frequen- number of neurons were generated, but there is a dramatic differ-
cies for 0.1, 1, or 10 ng/ml FGF2. The frequency distribu- ence in the percentage of clones containing glial cells. The numbers
tions are roughly bell-shaped, around a mean of approxi- of clones analyzed were: 151 for 0.1 ng/ml FGF2, 146 for 1 ng/ml
FGF2, and 137 for 10 ng/ml FGF2.mately 15 neurons per clone, with some cells generating
Neuron
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4 neurons or less and others generating >100 neurons. neurons, astrocytes, and oligodendrocytes (Davis and
Temple, 1994). Glial cells developing from stem cellsInterestingly, the distributions were very similar for 0.1,
1, and 10 ng/ml FGF2, and a paired Student t test does growing in basal medium plus added FGF2 were found
to be predominantly of the oligodendrocyte lineage: 98%not reveal a difference between any of the three sets of
data at the 95% confidence level. The average numbers of glia-containing clones that arose contained solely
O41 cells; only 2% contained GFAP1 astrocytes. In con-of neurons per clone in each FGF2 level, calculated from
data illustrated in Figure 6a, are also very similar–14.5 trast, when grown in the presence of cortical astrocyte–
meningeal cell-conditioned medium plus FGF2, >90%in 0.1, 15 in 1.0, and 15.3 neurons in 10 ng/ml. Because
the vast majority of the cells illustrated in this figure are of glia-containing clones included GFAP1 astrocytes (il-
lustrated in Figure 4J–4L). Growth in this conditionedmultipotent, we conclude that cortical stem cells are
heterogeneous in the number of neurons that they make, medium did not, however, change the percentage of
neurons and glia developing in clones at different FGF2and also that neuron production is not significantly influ-
enced by FGF2 concentration over this range. However, levels, only the types of glia present. In addition, it did
not significantly alter the total numbers of glial cellswe note that there is a possibility of some influence of
FGF2 level on neuron production shown by the fact that in clones (data not shown). We conclude that in basal
medium plus FGF2, glial production by stem cells isthe generation of glia-only clones increases from 0.5%
at 0.1 ng/ml FGF2 to 16% at 10 ng/ml FGF2. If the largely restricted to the oligodendrocyte lineage, and
that additional exogenous factors are required to stimu-glia-only clones present at high FGF2 levels arose from
multipotent cells that normally generate clones con- late astrocyte formation.
taining neurons at low FGF2 levels, then their neuron
production must have been inhibited at higher FGF2 Discussion
levels. Alternatively, these clones may have arisen from
a small percentage of restricted glial progenitor cells Multipotent cells that generate neurons and macroglia
that might be stimulated to divide in higher concentra- are found in most areas of the developing nervous sys-
tions of FGF2. If the lack of neurons in these clones tem (reviewed in Kilpatrick et al., 1995; Temple and Qian,
is in fact due to an inhibition of neuron production in 1996). Using a culture system that allows us to follow
multipotent cells, this is still a minor effect, given the the development of isolated CNS progenitor cells, we
small percentage of clones involved, and we can say that examined their fate when exposed to different FGF2
for cells that generate neurons, the number of neurons concentrations. Our results indicate that besides its role
produced does not vary significantly with FGF2 concen- as a mitogen for cortical progenitor cells, FGF2 plays a
tration. role in regulating the generation of neuronal and glial
In contrast, we found a dramatic effect of changes in cells from early cortical stem cells.
FGF2 concentrations over this range on glia production.
We examined whether clones that were categorized by
E10 Stem Cells Are Programmed to Generateneuron content, as shown in Figure 6a, also contained
Neurons, and Exposure to Low Levelsglial cells. Note that in this case, we are examining
of FGF2 Amplifies This Statewhether the clones contain glia at all, regardless of the
At E10, the cortical ventricular zone consists of neuro-number of glial cells per clone. As shown in Figure 6b,
epithelial cells that are initiating the neurogenic phasethe percentage of clones growing in 0.1 ng/ml FGF2 that
of cortical histogenesis. In vitro E10 stem cells can makecontained glia varied from 0–15%, the rest were purely
neurons and glia when given adequate growth condi-neuronal. In contrast, in 1 or 10 ng/ml FGF2, the propor-
tions. We questioned whether E10 stem cells are speci-tion of clones that contained glia was significantly
fied to generate both neuronal and glial fates at the timehigher, varying from 50%–100%.
of isolation. When E10 cortical cells are grown in basalWe have summarized these data in Figure 6c. This
medium alone, they tend to generate single neurons; ashows that the average numbers of neurons developing
few give small clones of neurons. When grown in 0.1–10in 0.1, 1, and 10 ng/ml, are very similar, around 15 cells,
FGF2, conditions that stimulate stem cell growth, thereand it also shows the dramatic change in the percentage
is no significant change in cell survival; however, theof clones that do or do not contain glia at these different
percentage of cells generating clones of four cells orFGF2 concentrations. Taken together, these data indi-
more increases from 1% to 8%–10%. Hence, the major-cate that increasing the concentration of FGF2 from 0.1
ity of stem cells that divide in 0.1–10 ng/ml FGF2 appearto 10 ng/ml influences whether E10 cortical stem cell
to arise from cells that give single neurons or smallclones will contain glial cells but does not have a signifi-
clones of neurons in basal medium. This suggests thatcant influence on their neuronal content, at least in terms
at the time of isolation, the majority of E10 cortical stemof neuron number.
cells are programmed to generate neurons. When these
cells are subsequently exposed to 0.1 ng/ml FGF2 in
vitro, stem cells can divide but >90% of them generateFGF2 Pushes the Multipotent Progenitor Cell
into the Oligodendrocyte Lineage; Astrocyte pure neuronal clones. They do not, at this low FGF2
level, generate small mixed clones or a random mixtureFormation Requires Additional
Environmental Factors of neuronal and glial clones. Hence, exposure to 0.1 ng/
ml FGF2 does not alter the fate of most of these stemMultipotent cortical stem cells grown in the presence
of membrane factors and cortical cell–conditioned me- cells; instead, by stimulating their proliferation, it ap-
pears to amplify their default neuronal state.dium can generate all three major neural cell classes:
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The number of neurons per cortical clone growing in within a cell or a population of cells, and environmental
factors act permissively to allow this program to be0.1–10 ng/ml FGF2 varies from 1 to around 100 cells.
Although the basis for this heterogeneity is not clear, read out. In this case the environmental factors do not
influence the direction of the fate pathway, and awe find it to be a consistent feature of these stem cells.
When the FGF2 concentration is raised from 0.1 to 10 multipotent progenitor cell competent to generate prog-
eny of more than one type will not change the cell typesng/ml, the number of neurons generated per clone does
not alter significantly: neuron production appears to be that it generates when exposed to these factors. To
create variety in the composition of multipotent cellmaximal for these growth conditions despite a 100-fold
increase in FGF2 level. One interpretation of these data clones by permissive mechanisms, selective processes,
such as cell death, are required.is that different E10 founder cells have different neuro-
genic potentials, and these are expressed at a maximum In the alternative mechanism, environmental factors
play an active role–they act instructively to alter the celllevel in 0.1–10 ng/ml FGF2. We conclude that FGF2
appears permissive for neuron production by stem cells types that a multipotent cell generates, hence directing
the fate pathway that the cell adopts (Slack, 1983). The(unless it is found in future studies that different classes
of neurons are induced at different FGF2 concentra- term “instructive” has also been used more specifically
to denote a factor that conveys information, rather thantions).
simply choosing between different, prespecified fate
programs (Holtzer, 1978). However, if the environment
Exposure to a Threshold Level of FGF2 Stimulates actively directs cell fate choices, even if the fates are
Multipotent Cells to Generate preprogrammed, the term “instructive” is applicable in
Glial Progeny both cases (Slack, 1983). We concur with this usage
We have shown that while 0.1 ng/ml FGF2 can support because it is current in the stem cell field (Shah et al.,
developmentof substantial clones from E10 cortical pro- 1994; 1996), although the terms “directive” or “active”
genitor cells, up to approximately 100 cells, 92% consist may be more appropriate to denote general, nonpermis-
purely of neurons. In contrast, in 1 or 10 ng/ml FGF2, sive mechanisms.
.75% of clones are mixed. By initiating cells in low Multipotent cortical stem cells can generate neurons
FGF2, then raising its concentration after 2 days, we and glial cells. Whether they generate glia does not
showed that the same group of founder cells that re- appear to depend on selection mechanisms. The output
spond to 0.1 ng/ml FGF2 can generate oligodendroglia of multipotent cortical founder cells is changed by an
at a higher concentration. This experiment showed that increase in FGF2 concentration, consistent with an in-
observed changes in clone composition could not be structive role for FGF2. In this in vitro setting, we have
explained by interclonal selection by FGF2 among sub- demonstrated that multipotent cortical stem cells have
populations of progenitor cells. Interestingly, the pro- a fate choice that is environmentally directed. Whether
portion of cells that produced glia when FGF2 levels this is an active, environmentally driven fate choice in
were raised after 2 days was less than the proportion vivo remains to be determined.
that did so when high FGF2 levels were present through- In this regard, the mechanism of FGF2 action appears
out the experiment (Figure 5). This suggests that some more similar to that of GGFII or TGFb family members
of the cells became committed to a neuronal phenotype on multipotent neural crest cell development, which also
during the first 2 days, and that for an individual stem instructively alter stem cell output, promoting glial or
cell, there may be a window of responsiveness to glial- neuronal production respectively (Shah et al., 1994;
promoting signals. 1996). In contrast, studies using a cell line model of
Having shown that interclonal selection could not ex- hemopoietic stem cells suggest that a major mechanism
plain the variation in clone composition observed at for generating particular blood cell types is via selection
different levels of FGF2, we went on to demonstrate that by exogenous factors among pools of different types of
our data also argue against intraclonal selection. By stem cell progeny (Fairbairn et al., 1993). The observa-
examining the development of identified cells in detail, tion that FGF2 can act to alter CNS progenitor cell fate,
we showed that in low (0.1 ng/ml) FGF2, thevast majority like GGF and BMPs on PNS progenitor cells, further
of stem cells and their progeny develop into neurons, delineates the nervous system from the blood system.
without producing glial progeny that die or do not de-
velop. We know that if glial progeny had been made,
they would most likely have been able to divide and Does FGF2 Stimulate Stem Cells to Generate
a Bipotent Glial Precursor with andifferentiate because glial progenitors present in a small
percentage of E10 clones and also glial progenitors ob- Oligodendrocyte Default State?
Cortical stem cells grown in complex culture conditionstained from E12 mouse cortex (data not shown) can
survive, divide, and differentiate in 0.1 ng/ml FGF2. In can generate all three major CNS cell types–neurons,
astrocytes, and oligodendrocytes (Davis and Temple,contrast, in high FGF2, the stem cell also generates glia
as well as neurons. Hence, as FGF2 level increases, a 1994). In contrast, when grown in 10 ng/ml FGF2, the
vast majority of glial cells generated are oligodendro-change is made in the fate of a stem cell or at least
some of its offspring so that they also develop along cytes. When cells are exposed to 10 ng/ml FGF2 plus
cortical astrocyte–meningeal cell-conditioned medium,the glial lineage instead of the neuronal lineage only.
Two classes of mechanisms for cell fate specification the percentage of clones producing glia is similar to that
in FGF2 alone, but the glia generated include astrocytesby environmental factors have been identified. In one,
the pathway of development is intrinsically programmed as well as oligodendrocytes. The overall number of glial
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cells per clone is roughly the same, suggesting that there ml. Alternatively, high levels of FGF2 may, like 0.1 ng/
is some substitution of astrocytes for oligodendrocytes. ml FGF2, stimulate pathways involved in stem cell divi-
One interpretation of these data is that FGF2 stimulates sion and may not have a separate influence on pathways
multipotent progenitor cells to generate a bipotential leading to glial cell specification. In this case, glial pro-
astrocyte–oligodendrocyte progenitor cell. Cells with duction from stem cells may be secondary to its role
these characteristics have been observed through ret- as a mitogen–stem cells could be preprogrammed to
roviral lineage tracing in the perinatal cortex in vivo (Le- generate glial progeny, providing that their proliferation
vison and Goldman, 1993). Further, these data are con- is maintained. This could occur if glial progeny are gen-
sistent with the hypothesis that the default state of this erated from multipotent stem cells only after all the neu-
putative glial progenitor is oligodendroglial, and that ronal progeny are made; it is not clear currently whether
additional environmental factors regulate its production this is the case, but it is possible. It might be argued that
of astrocytes. Recently, BMPs have been shown to stim- observation of an increase in clone size with increasing
ulate astroglial development from subventricular zone FGF2 concentration would support this type of mecha-
progenitor cells (Gross et al., 1996). BMPs have a dual nism. However, this phenomenon would also be ob-
action-stopping division as well as stimulating astroglial served if glial cells were specified through a separate
differentiation, whereas the conditioned medium used signaling mechanism. This is because in both cases,
in our experiments does not prevent proliferation of cor- stem cells undergo a change in fate from making neu-
tical progenitor cells. Serum and substrate components rons only to making essentially the same number of
have also been shown to influence astrocyte differentia- neurons and in addition glial progeny. In the presence
tion from cortical progenitor cells in mass cultures (Wil- of 0.1–10 ng/ml FGF2, glial progeny can divide much
liams and Price,1995). The astrocyte-stimulating activity longer than neuronal progeny, resulting in an increase
in cortical cell–conditioned mediumremains to be identi- in clone size in both cases. As shown in Figure 6 and
fied. We currently are pursuing the identity and charac- Table 1, this increase in clone size observed is almost
teristics of glial progenitor cells in stem cell clones. all attributable to the addition of glial progeny.
Our data suggest that it is unlikely that the influence
of FGF2 on glial cell production from stem cells is sec-
Mechanism of FGF2 Action ondary to its mitogenic role. On a cellular level, we have
FGF2 has a wide variety of actions–it can stimulate divi- seen that cortical stem cells have different neurogenic
sion, differentiation, and survival in a number of CNS potentials, and therefore that they require different num-
cell types (Baird, 1994; Kilpatrick et al., 1995). Although bers of cell divisions to complete the neuronal phase of
the signal transduction pathways underlying each bio- their development. If glial production is a consequence
logical effect have not been completely identified, recent
of maintaining the stem cells in division, then once this
studies have revealed that stimulation of different FGF
neurogenic phase was complete, they would be ex-
receptors can lead to activation of different intracellular
pected tostart making glial progeny.Because theprofile
signaling molecules, some in pathways distinct from
of neuron production is similar in 0.1 compared to 1 or
those involved in the mitogenic response (Wang and
10 ng/ml FGF2, as shown in Figure 6, it appears that 0.1
Goldfarb, 1994; Shaoul et al., 1995; reviewed in Friesel
ng/ml FGF2 allows stem cells to fulfill their neurogenic
and Macaig, 1995). Furthermore, different levels of acti-
phase of development. However, these cells do not go
vation of a single receptor subtype can result in different
on to generate glia. Note that some stem cells growing incellular responses (Marshall, 1995). The fact that several
0.1 ng/ml FGF2 stop dividing after generating 4 neurons,high affinity FGF receptors are expressed in E10 cortical
others do so after generating as many as 100 neurons,ventricular zone cells raises the possibility that an indi-
and neither make glia. If glial production were secondaryvidual cortical stem cell could express multiple FGF
to maintaining the cells in division, it would be veryreceptor combinations. Since FGF2 binds to specific
unlikely that a given FGF2 level would generate just theFGF receptors with different affinities, exposure to vari-
right number of divisions so that each heterogeneousous FGF2 concentrations is likely to activate different
stem cell would stop dividing at the point when it com-types and/or numbers of receptors. For example, ac-
pletes its neurogenic phase of development. On thecording to their relative affinities (see Johnson and Wil-
other hand, if glial production is specified by FGF2 vialiams, 1993), 0.1 ng/ml FGF2 is likely to stimulate FGFR1
a separate signaling mechanism, then it is likely thatand FGFR2 but have little effect on FGFR3. In contrast,
some low FGF2 level would support stem cells to com-1–10 ng/ml FGF2 is likely to activate FGFR3 as well as
plete their neurogenic phase and then cease develop-quantitatively more FGFR1 and FGFR2, compared to 0.1
ment–because at this FGF2 level, the signals for glialng/ml FGF2.
production are not activated or induced. Our data areGiven these possibilities, stimulation of cortical stem
compatible with this latter possibility. We can speculatecells with different concentrations of FGF2 may lead to
that, for example, higher levels of FGF2 but not low levelsactivation of different sets of signaling molecules. For
of FGF2 could alter the expression and/or activities ofexample, low FGF2 levels could stimulate signaling pro-
genes involved in glial cell fate specification, such as ateins involved in stem cell division while high FGF2 could
murine homolog of the Drosophila glial cells missingstimulate signaling molecules involved in cell division
(gcm) gene, which is important in regulating the choiceand in addition others involved in glial cell specification.
between neuronal and glial fates in the developing flyThis would be consistent with the observation that stem
nervous system (Hosoya et al., 1995; Jones et al., 1995).cells divide and generate only neurons in 0.1 ng/ml FGF2
but divide and generate neurons and glia in 1 or 10 ng/ It could also modulate the activity of neurogenic HLH
FGF2 and Stem Cells in Cerebral Cortex
91
proteins, by analogy with its ability to suppress myogen- cortical development warrants further detailed examina-
tion of the activities of FGF2 and other family membersesis through inhibition of myogenic HLH proteins (Li et
al., 1992). in the developing ventricular zone and their influence
on progenitor cell development at the cellular and mo-
lecular levels.
Could FGF2 Regulate the Generation of Neurons
and Glia In Vivo? Experimental Procedures
Key questions pertinent to our understanding of cortical
Preparation of Single-Cell Suspensions and Cell Culturedevelopment concern how the fate choices of multipo-
Timed pregnant Swiss Webster mouse embryos (Taconic farms) attent progenitor cells are regulated so that appropriate
E10 (plug date was defined as day 0) were used. Dissected cortices
numbers of different neural cell types are generated in were mechanically dissociated by trituration in hibernation medium
vivo. In addition, the scheduled appearance of neurons (Kawamoto and Barrett, 1986) at room temperature. The suspension
and glia iskey for thenormal patterning of cortical tissue, was settled at 1 g for 10–15 min to separate single cells. Cells were
plated into poly-L-lysine-coated Terasaki microwells containing cul-and we need to understand how this occurs. Regulation
ture medium, usually at a density of 2–3 cells per well, incubatedof neuronal and glial production in vivo is likely to involve
for 2 hr and then observed by an inverted Nikon microscope tofactors within developing cortical cells and also in their
check for cell clusters. Any wells containing clusters of >1 cell were
environment (Jacobson, 1991; McConnell, 1995). As yet, removed from the experiment. (Of the plated cells, >98% are rou-
no environmental factor has been identified with this tinely found to be single cells).
kind of activity for cortical ventricular zone cells. Inter- The basal culture medium used was DMEM, supplemented with
N2 and B27 (GIBCO). In some cases, the medium was conditionedestingly, levels of FGF2 mRNA and protein increase sig-
for 3 days by cultures of neonatal astrocytes and meningeal cells,nificantly between E15 and E18, coincident with early
as described previously (Davis and Temple, 1994). FGF2 (humanphases of gliogenesis (Powell et al., 1991; Giordano et
recombinant, RandD) was used at final concentrations of 0.1–10 ng/
al., 1992). We have now shown that early embryonic ml and maintained by adding 50% of the initial concentration every
stem cells are programmed to generate neurons, and 48–72 hrs. Cultures were incubated for up to 14 days at 358C with
that in low levels of FGF2, they maintain this neuronal 5% CO2 and 100% humidity.
fate. High FGF2 levels direct these cells to generate
BrdU Incorporation Assayglial progeny, and further environmental factors direct
Cells were plated into Terasaki microwells at a density of 20–40astrocyte formation. These data are consistent with the
cells per well in basal culture medium with different concentrationshypothesis that the production of cortical neurons and
of recombinant FGF2, ranging from 0–100 ng/ml. After 24 hr, BrdU
glia depends on an intrinsic neuronal program in the was added to the wells at 10 mg/ml and incubated for 18 hr. Cells
stem cell and the timely production of environmental were then fixed and processed for BrdU staining as previously de-
scribed (Temple and Davis, 1994), using an anti-BrdU antibody di-signals to direct glial production. Interestingly, in-
rectly conjugated to fluorescein (Becton-Dickenson). Cells with ei-creased levels of FGF2 are made by differentiating corti-
ther positive or negative nuclear staining werecounted by examiningcal neurons (Weise et al., 1993). This could provide a
stained cultures with a Zeiss Axiovert 35 fluorescence inverted mi-feedback mechanism whereby early neuron production
croscope.
raises FGF2 levels, which in turn stimulates glia genera-
tion from responsive stem cells. A similar feedback Immunohistochemistry
mechanism has been suggested to regulate neural crest Cultures were rinsed with room temperature calcium–magnesium
containing phosphate-buffered saline (CMPBS) and fixed with ice-stem cell development (Shah et al., 1994).
cold 4% paraformaldehyde, either for 10 min (for O4 stain) or for 30Given its complex expression in the early cortical ven-
min. Cultures fixed for 10 min were stained to detect oligodendro-tricular zone, and its influence on stem cell development
cyte lineage cells using the O4 monoclonal antibody (Sommer and
demonstrated in vitro, FGF2 is a likely candidate regula- Schachner, 1981), as described (Davis and Temple, 1994), and then
tor of neuron and glial production in vivo. The fact that refixed for 20 more min in 4% paraformaldehyde. Fixed cultures
a variety of FGFR are expressed in the early cortical were permeated by exposure to methanol at 2208C for 5 min. Cells
were subsequently stained using a monoclonal antibody againstventricular zone opens the further possibility that other
beta-tubulin isoform III (1:100 dilution, Sigma) and/or a polyclonalendogenous FGF family members could also play a role
antiserum against GFAP (1:400 dilution, Dako) to identify neuronsin this process. FGF1 is known to be present in the
and/or astrocytes, respectively. Briefly, fixed cultures are blocked
embryonic murine brain after E11, and FGF8 is ex- by incubation in CMPBS with 10% normal goat serum for 30 min,
pressed in discrete regions of the developing murine then incubated with primary antibody for either 30 min at room
telencephalon (Nurcombe et al., 1993; Crossley and temperature (O4 and GFAP) or overnight at 48C (beta-tubulin III).
Cells were then washed four times with CMPBS and blocked withMartin, 1995). The expression patterns of other FGFs
10% normal goat serum before incubating with secondary antibod-that activate the receptors present on cortical ventricu-
ies (1:75–100, diluted in CMPBS with 5% normal goat serum) for 30lar zone cells, including FGF9, are not clear at this point.
min. FITC-conjugated goat-anti-mouse IgG and IgM (Cappel) were
We are assessing the influence of otherFGF family mem- used to detect O4, and beta-tubulin III and rhodamine-conjugated
bers on the fate of cortical founder cells in vitro. anti-rabbit IgGs (Cappel) were used to detect GFAP staining. Finally,
In conclusion, these studies have revealed further in- stained cells were washed with CMPBS three times and mounted
in PBS containing 25 mM NaI to reduce fading before examinationsights into the behavior of progenitor cells from the early
with a Zeiss Axiovert 35 fluorescence microscope.embryonic cortical ventricular zone. Our observations
suggest that early cortical stem cells exhibit a default
RNA Preparation and RT-PCRneuronal phenotype that is preserved in low levels of
Embryonic cortices from E10, E12, and E14 embryos were dissected
FGF2, and that spatial and/or temporal increases in and immediately placed into tubes held in liquid nitrogen. Total RNA
FGF2 concentration can direct the production of glia was extracted using Qiagen RNeasy Total RNA kit. Total RNA (5 mg)
were then used in first stand cDNA synthesis. Briefly, 5 mg RNAfrom these cells. The implication of this possibility for
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were mixed with 1 mg Oligo(dT)15 primer in 20 ml H2O at 758C for energy-dependent, non-ER/Golgi pathway. J. Cell. Physiol. 162,
388–399.10 mins; the remaining cDNA synthesis components were added
(final concentration: 50 mM MgCl2, 13 RT buffer, 1 mM dNTPs, 1 Friesel, R.E., and Macaig, T. (1995). Molecular mechanisms of angio-
U/ml RNasin, and 10U/mg RNAAMV reverse transcriptase[Promega] genesis: fibroblast growth factor signal transduction. FASEB J. 9,
in 40 ml volume), and the tubes were cooled to room temperature. 919–925.
The tubes were subsequently placed in a 428C water bath for 1 hr
Ghosh, A., and Greenberg, M.E. (1995). Distinct roles for bFGF andand then heated at 988C for 5 min before being quickly chilled in
NT-3 in the regulation of cortical neurogenesis. Neuron 15, 1–20.ice water. Of the cDNA reaction products, 2 ml were used in each
Giordano, S., Sherman, L., Lyman, W., andMorrison, R. (1992). Multi-PCR reaction of 25 ml total volume, performed in the GeneAMP 9600
ple molecular weight forms of basic fibroblast factor are develop-PCR System (Perkin Elmer). The general PCR profile followed was:
mentally regulated in the central nervous system. Dev. Biol. 152,958C for 4 min, 958C for 1 min, 588C for 1 min, and 728C for 1 min
293–303.for 32 cycles, followed by incubating for 10 min at 728C. PCR prod-
ucts were analyzed on a 2.5% TBE gel. PCR primers, designed Gritti, A., Parati, E.A., Cova, L., Frolichsthal, P., Galli, R., Wanke, E.,
between exon II and either exon IIIa, or IIIb, or IIIc, based on Brick- Faravelli, L., Morassutti, D.J., Roisen, F., Nickel, D.D., and Vescovi,
man et al., 1995, for each FGF receptor isoforms were as follows: A. (1996). Multipotential stem cells from the adult mouse brain prolif-
1 and 2, FGFR1 IIIa; 1 and 3, FGFR1 IIIb; 1 and 4, FGFR1 IIIc; 5 and erate and self-renew in response to basic fibroblast growth factor.
6, FGFR2 IIIc; 7 and 8, FGFR3 IIIb; 7 and 9, FGFR3, IIIc; and 10 and J. Neurosci. 16, 1091–1100.
11, FGFR4. Gross, R.E., Mehler, M.F., Mabie, P.C., Zang, Z., Santschi, L., and
1 CTTGACGTCGTGGAACGATCT Kessler, J.A. (1996). Bone morphogenic proteins promote astroglial
2 GCCAAGAAAGGAGGTTAAGAGTAC lineage commitment by mammalian subventricular zone progenitor
3 CTGGTTAGCTTCACTAATAT cells. Neuron, 17, 595–606.
4 TTCCAGAACGGTCAACCATGCAGA
Holzter, H. (1978). Cell lineages, stem cells and the ‘‘quantal’’ cell5 CCCATCCTCCAAGCTGGACTGCCT
cycle concept. (1978). In Stem Cells and Hemostasis, BCSB Sympo-6 CTCCTTCTCTCTCACAGGCGC
sium, 2nd Ed., (Cambridge: Cambridge University Press), pp. 2–27.7 GACAGACACACGGATGTGCTGGA
8 GTGAACACGCAGCAAAAGGCTTT Hosoya, T., Takizawa, K., Nitta, K., and Hotta, Y. (1995). Glial cells
missing: a binary switch between neuronal and glial determination9 AGCACCACCAGCCACGCAGAG
10 TACAGCTATCTCCTGGATGTGCTG in Drosophila. Cell 82, 1025–1036.
11 GAAACCGTCGGCGCCGAAGCTGCT Jacobson, M. (1991). Developmental Neurobiology, 3rd Ed. (New
York: Plenum Press).
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